Ovarian Cancer Coverage from Every Angle
Advertisement
Advertisement

Tingyan Shi, MD, PhD, on Clinical Implications of Using Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer

Posted: Tuesday, June 9, 2020

Tingyan Shi, MD, PhD, of Zhongshan Hospital, Fudan University, discusses the possible survival benefits of cytoreductive surgery in selected patients with ovarian cancer and whether the findings are significant enough for clinicians to offer it to patients now.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.